Ylinen P, et al. - An analysis was conducted of the anti-inflammatory effectiveness and tolerance of preservative-free dexamethasone (DEX) and diclofenac (DICL) eye drops, and their combination following cataract surgery. Data demonstrated that diclofenac (DICL), along with DEX plus DICL, were superior to DEX monotherapy in minimizing CRT change and the incidence of PCME. In the cases of uneventful cataract surgery, combination medication did not disclose any added value compared to DICL monotherapy.